Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate

Method of treatment of tumors that are resistant to EGFR antibody therapies by EGFR antibody cytotoxic agent conjugate

US Patent 9233171 · Granted Jan 12, 2016

Estimated economic value: $19,654,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bicyclic peptide ligands specific for Nectin-42025
Multimeric bicyclic peptide ligands2025
Bicyclic peptide ligands specific for CD1372024
Method for increasing the efficacy of cancer therapy by administering an anti-FO2024
Bicyclic peptide ligands specific for nectin-42024
Anti-CD123 antibodies and conjugates and derivatives thereof2024
Biparatopic FR-alpha antibodies and immunoconjugates2023
Biparatopic FR-alpha antibodies and immunoconjugates2023
Bicyclic peptide ligands specific for OX402023
Multimeric bicyclic peptide ligands2023
Monoclonal antibodies against HER2 epitope and methods of use thereof2022
CD37-binding molecules and immunoconjugates thereof2022